The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: Short waiting time and excellent graft outcome
Claas FH Witvliet MD Duquesnoy RJ Persijn GG Doxiadis II. The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: short waiting time and excellent graft outcome. Transplantation 2004 78: 190 193.
Suppression of HLA-specific alloantibodies by high-dose intravenous immunoglobulins (IVIg). a potential tool for transplantation of immunized patients
Glotz D Haymann JP Sansonetti N et al. Suppression of HLA-specific alloantibodies by high-dose intravenous immunoglobulins (IVIg). A potential tool for transplantation of immunized patients. Transplantation 1993 56: 335 337.
Effect of high-dose intravenous immunoglobulin on suppression of alloantibodies against HLA in highly sensitized transplant candidates
Mahmoud K Sobh M El-Shenawy F et al. Effect of high-dose intravenous immunoglobulin on suppression of alloantibodies against HLA in highly sensitized transplant candidates. Transplant Proc 2004 36: 1850 1852.
A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection
Casadei DH del C Rial M Opelz G et al. A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection. Transplantation 2001 71: 53 58.
Differential inhibitory effects of intravenous immunoglobulin preparations on HLA-alloantibodies in vitro
Wassmuth R Hauser IA Schuler K et al. Differential inhibitory effects of intravenous immunoglobulin preparations on HLA-alloantibodies in vitro. Transplantation 2001 71: 1436 1442.
No advantage of flow cytometry crossmatch over complement-dependent cytotoxicity in immunologically well-documented renal allograft recipients
Christiaans MH Overhof R ten Haaft A Nieman F van Hooff JP van den Berg-Loonen EM. No advantage of flow cytometry crossmatch over complement-dependent cytotoxicity in immunologically well-documented renal allograft recipients. Transplantation 1996 62: 1341 1347.